{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T17:53:45Z","timestamp":1790963625335,"version":"4.1.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2021,1,13]],"date-time":"2021-01-13T00:00:00Z","timestamp":1610496000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,13]],"date-time":"2021-01-13T00:00:00Z","timestamp":1610496000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1038\/s41401-020-00578-0","type":"journal-article","created":{"date-parts":[[2021,1,13]],"date-time":"2021-01-13T09:03:27Z","timestamp":1610528607000},"page":"1653-1664","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["A novel tricyclic BTK inhibitor suppresses B cell responses and osteoclastic bone erosion in rheumatoid arthritis"],"prefix":"10.1038","volume":"42","author":[{"given":"Yu-ting","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-hua","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ze-min","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Que","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang-shuang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-qian","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng-hua","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue-teng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-qi","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang-ming","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi-lan","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei-yu","family":"Geng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-jun","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-ping","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,13]]},"reference":[{"key":"578_CR1","first-page":"S295","volume":"18","author":"A Gibofsky","year":"2012","unstructured":"Gibofsky A. Overview of epidemiology, pathophysiology, and diagnosis of rheumatoid arthritis. Am J Managed Care. 2012;18:S295\u2013302.","journal-title":"Am J Managed Care"},{"key":"578_CR2","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/nature01661","volume":"423","author":"GS Firestein","year":"2003","unstructured":"Firestein GS. Evolving concepts of rheumatoid arthritis. Nature. 2003;423:356\u201361.","journal-title":"Nature"},{"key":"578_CR3","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1056\/NEJMra1004965","volume":"365","author":"IB McInnes","year":"2011","unstructured":"McInnes IB, Schett G. The pathogenesis of rheumatoid arthritis. N Engl J Med. 2011;365:2205\u201319.","journal-title":"N Engl J Med"},{"key":"578_CR4","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s00281-017-0627-z","volume":"39","author":"V Derksen","year":"2017","unstructured":"Derksen V, Huizinga TWJ, van der Woude D. The role of autoantibodies in the pathophysiology of rheumatoid arthritis. Semin Immunopathol. 2017;39:437\u201346.","journal-title":"Semin Immunopathol"},{"key":"578_CR5","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/s41413-018-0016-9","volume":"6","author":"Q Guo","year":"2018","unstructured":"Guo Q, Wang Y, Xu D, Nossent J, Pavlos NJ, Xu J. Rheumatoid arthritis: pathological mechanisms and modern pharmacologic therapies. Bone Res. 2018;6:15.","journal-title":"Bone Res"},{"key":"578_CR6","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1038\/s41401-018-0196-2","volume":"40","author":"XY Jia","year":"2019","unstructured":"Jia XY, Chang Y, Wei F, Dai X, Wu YJ, Sun XJ, et al. CP-25 reverses prostaglandin E4 receptor desensitization-induced fibroblast-like synoviocyte dysfunction via the G protein-coupled receptor kinase 2 in autoimmune arthritis. Acta Pharmacol Sin. 2019;40:1029\u201339.","journal-title":"Acta Pharmacol Sin."},{"key":"578_CR7","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1038\/s41401-019-0337-2","volume":"41","author":"L Han","year":"2020","unstructured":"Han L, Zhang XZ, Wang C, Tang XY, Zhu Y, Cai XY, et al. IgD-Fc-Ig fusion protein, a new biological agent, inhibits T cell function in CIA rats by inhibiting IgD-IgDR-Lck-NF-kappaB signaling pathways. Acta Pharmacol Sin. 2020;41:800\u201312.","journal-title":"Acta Pharmacol Sin"},{"key":"578_CR8","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.3389\/fimmu.2019.01483","volume":"10","author":"U Steffen","year":"2019","unstructured":"Steffen U, Schett G, Bozec A. How autoantibodies regulate osteoclast induced bone loss in rheumatoid arthritis. Front Immunol. 2019;10:1483.","journal-title":"Front Immunol"},{"key":"578_CR9","doi-asserted-by":"publisher","first-page":"10729","DOI":"10.1073\/pnas.1301001110","volume":"110","author":"M Seeling","year":"2013","unstructured":"Seeling M, Hillenhoff U, David JP, Schett G, Tuckermann J, Lux A, et al. Inflammatory monocytes and Fc\u03b3 receptor IV on osteoclasts are critical for bone destruction during inflammatory arthritis in mice. Proc Natl Acad Sci USA. 2013;110:10729\u201334.","journal-title":"Proc Natl Acad Sci USA"},{"key":"578_CR10","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1002\/jbmr.3158","volume":"32","author":"C Engdahl","year":"2017","unstructured":"Engdahl C, Bang H, Dietel K, Lang SC, Harre U, Schett G. Periarticular bone loss in arthritis is induced by autoantibodies against citrullinated vimentin. J Bone Miner Res. 2017;32:1681\u201391.","journal-title":"J Bone Miner Res"},{"key":"578_CR11","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/S8756-3282(01)00420-3","volume":"28","author":"M Komine","year":"2001","unstructured":"Komine M, Kukita A, Kukita T, Ogata Y, Hotokebuchi T, Kohashi O. Tumor necrosis factor-alpha cooperates with receptor activator of nuclear factor kappaB ligand in generation of osteoclasts in stromal cell-depleted rat bone marrow cell culture. Bone. 2001;28:474\u201383.","journal-title":"Bone"},{"key":"578_CR12","doi-asserted-by":"publisher","first-page":"4858","DOI":"10.1074\/jbc.275.7.4858","volume":"275","author":"Y Azuma","year":"2000","unstructured":"Azuma Y, Kaji K, Katogi R, Takeshita S, Kudo A. Tumor necrosis factor-alpha induces differentiation of and bone resorption by osteoclasts. J Biol Chem. 2000;275:4858\u201364.","journal-title":"J Biol Chem"},{"key":"578_CR13","doi-asserted-by":"publisher","first-page":"11526","DOI":"10.1074\/jbc.M708935200","volume":"283","author":"SH Lee","year":"2008","unstructured":"Lee SH, Kim T, Jeong D, Kim N, Choi Y. The tec family tyrosine kinase Btk Regulates RANKL-induced osteoclast maturation. J Biol Chem. 2008;283:11526\u201334.","journal-title":"J Biol Chem"},{"key":"578_CR14","doi-asserted-by":"publisher","first-page":"100201","DOI":"10.1016\/j.bonr.2019.100201","volume":"10","author":"Y Ariza","year":"2019","unstructured":"Ariza Y, Murata M, Ueda Y, Yoshizawa T. Bruton\u2019s tyrosine kinase (Btk) inhibitor tirabrutinib suppresses osteoclastic bone resorption. Bone Rep. 2019;10:100201.","journal-title":"Bone Rep."},{"key":"578_CR15","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1016\/j.cell.2007.12.037","volume":"132","author":"M Shinohara","year":"2008","unstructured":"Shinohara M, Koga T, Okamoto K, Sakaguchi S, Arai K, Yasuda H, et al. Tyrosine kinases Btk and Tec regulate osteoclast differentiation by linking RANK and ITAM signals. Cell. 2008;132:794\u2013806.","journal-title":"Cell"},{"key":"578_CR16","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.bone.2013.11.025","volume":"60","author":"M Shinohara","year":"2014","unstructured":"Shinohara M, Chang BY, Buggy JJ, Nagai Y, Kodama T, Asahara H, et al. The orally available Btk inhibitor ibrutinib (PCI-32765) protects against osteoclast-mediated bone loss. Bone. 2014;60:8\u201315.","journal-title":"Bone"},{"key":"578_CR17","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1111\/j.1600-065X.2000.imr017504.x","volume":"175","author":"AB Satterthwaite","year":"2000","unstructured":"Satterthwaite AB, Witte ON. The role of Bruton\u2019s tyrosine kinase in B-cell development and function: a genetic perspective. Immunol Rev. 2000;175:120\u20137.","journal-title":"Immunol Rev"},{"key":"578_CR18","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1128\/MCB.24.6.2455-2466.2004","volume":"24","author":"MG Tomlinson","year":"2004","unstructured":"Tomlinson MG, Kane LP, Su J, Kadlecek TA, Mollenauer MN, Weiss A. Expression and function of Tec, Itk, and Btk in lymphocytes: evidence for a unique role for Tec. Mol Cell Biol. 2004;24:2455\u201366.","journal-title":"Mol Cell Biol"},{"key":"578_CR19","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1038\/leu.2014.351","volume":"29","author":"K Musilova","year":"2015","unstructured":"Musilova K, Mraz M. MicroRNAs in B-cell lymphomas: how a complex biology gets more complex. Leukemia. 2015;29:1004\u201317.","journal-title":"Leukemia"},{"key":"578_CR20","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s13075-016-0957-6","volume":"18","author":"Y Ota","year":"2016","unstructured":"Ota Y, Niiro H, Ota S, Ueki N, Tsuzuki H, Nakayama T, et al. Generation mechanism of RANKL(+) effector memory B cells: relevance to the pathogenesis of rheumatoid arthritis. Arthritis Res Ther. 2016;18:67.","journal-title":"Arthritis Res Ther"},{"key":"578_CR21","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1002\/art.24505","volume":"60","author":"JA Hamilton","year":"2009","unstructured":"Hamilton JA, Tak PP. The dynamics of macrophage lineage populations in inflammatory and autoimmune diseases. Arthritis Rheum. 2009;60:1210\u201321.","journal-title":"Arthritis Rheum"},{"key":"578_CR22","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1002\/cmdc.200600221","volume":"2","author":"Z Pan","year":"2007","unstructured":"Pan Z, Scheerens H, Li SJ, Schultz BE, Sprengeler PA, Burrill LC, et al. Discovery of selective irreversible inhibitors for Bruton\u2019s tyrosine kinase. ChemMedChem. 2007;2:58\u201361.","journal-title":"ChemMedChem"},{"key":"578_CR23","doi-asserted-by":"publisher","first-page":"13075","DOI":"10.1073\/pnas.1004594107","volume":"107","author":"LA Honigberg","year":"2010","unstructured":"Honigberg LA, Smith AM, Sirisawad M, Verner E, Loury D, Chang B, et al. The Bruton tyrosine kinase inhibitor PCI-32765 blocks B-cell activation and is efficacious in models of autoimmune disease and B-cell malignancy. Proc Natl Acad Sci USA. 2010;107:13075\u201380.","journal-title":"Proc Natl Acad Sci USA"},{"key":"578_CR24","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1124\/jpet.117.242909","volume":"363","author":"T Barf","year":"2017","unstructured":"Barf T, Covey T, Izumi R, van de Kar B, Gulrajani M, van Lith B, et al. Acalabrutinib (ACP-196): a covalent Bruton tyrosine kinase inhibitor with a differentiated selectivity and in vivo potency profile. J Pharmacol Exp Ther. 2017;363:240\u201352.","journal-title":"J Pharmacol Exp Ther"},{"key":"578_CR25","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1177\/2472555218786165","volume":"23","author":"H Yu","year":"2018","unstructured":"Yu H, Truong H, Mitchell SA, Liclican A, Gosink JJ, Li W, et al. Homogeneous BTK occupancy assay for pharmacodynamic assessment of tirabrutinib (GS-4059\/ONO-4059) target engagement. SLAS Discov. 2018;23:919\u201329.","journal-title":"SLAS Discov"},{"key":"578_CR26","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1124\/jpet.113.203489","volume":"346","author":"EK Evans","year":"2013","unstructured":"Evans EK, Tester R, Aslanian S, Karp R, Sheets M, Labenski MT, et al. Inhibition of Btk with CC-292 provides early pharmacodynamic assessment of activity in mice and humans. J Pharmacol Exp Ther. 2013;346:219\u201328.","journal-title":"J Pharmacol Exp Ther"},{"key":"578_CR27","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1124\/jpet.106.101113","volume":"318","author":"R Zhou","year":"2006","unstructured":"Zhou R, Tang W, Ren YX, He PL, Zhang F, Shi LP, et al. (5R)-5-hydroxytriptolide attenuated collagen-induced arthritis in DBA\/1 mice via suppressing interferon-gamma production and its related signaling. J Pharmacol Exp Ther. 2006;318:35\u201344.","journal-title":"J Pharmacol Exp Ther"},{"key":"578_CR28","doi-asserted-by":"publisher","first-page":"R114","DOI":"10.1186\/ar1039","volume":"6","author":"C Schramm","year":"2004","unstructured":"Schramm C, Kriegsmann J, Protschka M, Huber S, Hansen T, Schmitt E, et al. Susceptibility to collagen-induced arthritis is modulated by TGFbeta responsiveness of T cells. Arthritis Res Ther. 2004;6:R114\u20139.","journal-title":"Arthritis Res Ther"},{"key":"578_CR29","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1093\/rheumatology\/keq404","volume":"50","author":"Y Chang","year":"2011","unstructured":"Chang Y, Wu Y, Wang D, Wei W, Qin Q, Xie G, et al. Therapeutic effects of TACI-Ig on rats with adjuvant-induced arthritis via attenuating inflammatory responses. Rheumatology (Oxford). 2011;50:862\u201370.","journal-title":"Rheumatology (Oxford)"},{"key":"578_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/srep38115","volume":"6","author":"ZM Lin","year":"2016","unstructured":"Lin ZM, Yang XQ, Zhu FH, He SJ, Tang W, Zuo JP. Artemisinin analogue SM934 attenuate collagen-induced arthritis by suppressing T follicular helper cells and T helper 17 cells. Sci Rep. 2016;6:38115.","journal-title":"Sci Rep."},{"key":"578_CR31","doi-asserted-by":"publisher","first-page":"2445","DOI":"10.1002\/art.30392","volume":"63","author":"LF Hou","year":"2011","unstructured":"Hou LF, He SJ, Li X, Yang Y, He PL, Zhou Y, et al. Oral administration of artemisinin analog SM934 ameliorates lupus syndromes in MRL\/lpr mice by inhibiting Th1 and Th17 cell responses. Arthritis Rheum. 2011;63:2445\u201355.","journal-title":"Arthritis Rheum"},{"key":"578_CR32","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/aps.2013.167","volume":"35","author":"SJ He","year":"2014","unstructured":"He SJ, Lin ZM, Wu YW, Bai BX, Yang XQ, He PL, et al. Therapeutic effects of DZ2002, a reversible SAHH inhibitor, on lupus-prone NZB\u00d7NZW F1 mice via interference with TLR-mediated APC response. Acta Pharmacol Sin. 2014;35:219\u201329.","journal-title":"Acta Pharmacol Sin"},{"key":"578_CR33","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1016\/j.intimp.2009.09.003","volume":"9","author":"LF Hou","year":"2009","unstructured":"Hou LF, He SJ, Wang JX, Yang Y, Zhu FH, Zhou Y, et al. SM934, a water-soluble derivative of arteminisin, exerts immunosuppressive functions in vitro and in vivo. Int Immunopharmacol. 2009;9:1509\u201317.","journal-title":"Int Immunopharmacol"},{"key":"578_CR34","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1097\/01.bor.0000231912.24740.a5","volume":"18","author":"K Sato","year":"2006","unstructured":"Sato K, Takayanagi HOsteoclasts. rheumatoid arthritis, and osteoimmunology. Curr Opin Rheumatol. 2006;18:419\u201326.","journal-title":"Curr Opin Rheumatol"},{"key":"578_CR35","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/nchembio.481","volume":"7","author":"JA Di Paolo","year":"2011","unstructured":"Di Paolo JA, Huang T, Balazs M, Barbosa J, Barck KH, Bravo BJ, et al. Specific Btk inhibition suppresses B cell- and myeloid cell-mediated arthritis. Nat Chem Biol. 2011;7:41\u201350.","journal-title":"Nat Chem Biol"},{"key":"578_CR36","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1002\/1529-0131(200105)44:5<1003::AID-ANR179>3.0.CO;2-#","volume":"44","author":"S Kotake","year":"2001","unstructured":"Kotake S, Udagawa N, Hakoda M, Mogi M, Yano K, Tsuda E, et al. Activated human T cells directly induce osteoclastogenesis from human monocytes: possible role of T cells in bone destruction in rheumatoid arthritis patients. Arthritis Rheum. 2001;44:1003\u201312.","journal-title":"Arthritis Rheum"},{"key":"578_CR37","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/nm.3432","volume":"20","author":"N Komatsu","year":"2014","unstructured":"Komatsu N, Okamoto K, Sawa S, Nakashima T, Oh-hora M, Kodama T, et al. Pathogenic conversion of Foxp3+T cells into TH17 cells in autoimmune arthritis. Nat Med. 2014;20:62\u20138.","journal-title":"Nat Med"},{"key":"578_CR38","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1002\/1529-0131(200002)43:2<259::AID-ANR4>3.0.CO;2-W","volume":"43","author":"H Takayanagi","year":"2000","unstructured":"Takayanagi H, Iizuka H, Juji T, Nakagawa T, Yamamoto A, Miyazaki T, et al. Involvement of receptor activator of nuclear factor kappaB ligand\/osteoclast differentiation factor in osteoclastogenesis from synoviocytes in rheumatoid arthritis. Arthritis Rheum. 2000;43:259\u201369.","journal-title":"Arthritis Rheum"},{"key":"578_CR39","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1136\/ard.2011.153312","volume":"70","author":"L Yeo","year":"2011","unstructured":"Yeo L, Toellner KM, Salmon M, Filer A, Buckley CD, Raza K, et al. Cytokine mRNA profiling identifies B cells as a major source of RANKL in rheumatoid arthritis. Ann Rheum Dis. 2011;70:2022\u20138.","journal-title":"Ann Rheum Dis"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41401-020-00578-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-020-00578-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-020-00578-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,11]],"date-time":"2022-12-11T11:27:27Z","timestamp":1670758047000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41401-020-00578-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,13]]},"references-count":39,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["578"],"URL":"https:\/\/doi.org\/10.1038\/s41401-020-00578-0","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,13]]},"assertion":[{"value":"4 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}